Invitae Corporation DPO Ratio 2011-2026 | NVTA

Annual DPO Ratio Invitae Corporation

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
69	88	32.7	31.9	35.6	62.6	43.9	77.3	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
88	31.9	55.1

Quarterly DPO Ratio Invitae Corporation

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
26.8	18.2	13.3	-	14.6	28.3	29.5	26.8	34.7	35.9	38.8	33.7	49.3	53.5	40.1	25.6	29.3	33.6	38.9	33.7	34.9	34.9	41.4	46.1	59.2	74.9	58.5	-	42.2	47.2	52.2	-	80.8	82.6	90.7	-	155	271	214	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
271	13.3	56.9

DPO Ratio of other stocks in the Diagnostics research industry

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	120	-	-6.23 %	$ 30.6 M	Germany
Accelerate Diagnostics AXDX	125	-	-61.36 %	$ 2.46 M	USA
Agilent Technologies A	50.1	$ 115.55	3.81 %	$ 35.1 B	USA
CareDx, Inc CDNA	44.2	$ 20.81	0.05 %	$ 1.11 B	USA
Co-Diagnostics CODX	4.24 K	$ 1.55	1.31 %	$ 2.06 M	USA
Castle Biosciences CSTL	52	$ 24.49	1.03 %	$ 680 M	USA
Akumin AKU	21.3	-	-17.87 %	$ 25.9 M	Canada
Biocept BIOC	56.3	-	-13.05 %	$ 7.29 M	USA
Fulgent Genetics FLGT	34.9	$ 15.19	2.64 %	$ 459 M	USA
Aspira Women's Health AWH	189	-	-6.19 %	$ 10.5 M	USA
Chembio Diagnostics CEMI	52.5	-	0.22 %	$ 16.8 M	USA
Oxford Immunotec Global PLC OXFD	45.8	-	-	$ 562 M	Britain
Heska Corporation HSKA	39.7	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	112	-	-20.0 %	$ 1.06 M	USA
ICON Public Limited Company ICLR	6.52	$ 118.33	1.86 %	$ 9.76 B	Irlanda
Illumina ILMN	56.3	$ 126.74	5.29 %	$ 20.2 B	USA
DermTech DMTK	47.4	-	-11.32 %	$ 2.94 M	USA
Global Cord Blood Corporation CO	17.7	-	-	$ 399 M	China
Fluidigm Corporation FLDM	61.4	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	780	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	43.5	-	0.12 %	$ 80.1 M	China
Charles River Laboratories International CRL	24.5	$ 166.97	1.91 %	$ 8.28 B	USA
PRA Health Sciences, Inc. PRAH	8.98	-	-	$ 10.7 B	USA
Lantheus Holdings LNTH	23.6	$ 84.62	4.25 %	$ 5.71 B	USA
Enzo Biochem ENZ	52.3	-	-8.98 %	$ 14.8 K	USA
Exact Sciences Corporation EXAS	49.2	-	-	$ 19.8 B	USA
Medpace Holdings MEDP	13.3	$ 418.66	1.23 %	$ 12.1 B	USA
Guardant Health GH	48.6	$ 87.08	4.4 %	$ 10.9 B	USA
Motus GI Holdings MOTS	1.72	-	-34.28 %	$ 263 K	Israel
Myriad Genetics MYGN	45.9	$ 4.75	1.5 %	$ 440 M	USA
Interpace Biosciences IDXG	33	$ 1.98	-0.5 %	$ 8.76 M	USA
NeoGenomics NEO	19.7	$ 9.26	3.35 %	$ 1.19 B	USA
QIAGEN N.V. QGEN	50	-	-	$ 10.6 B	Niderland
Biomerica BMRA	32.4	$ 2.18	0.93 %	$ 5.01 M	USA
Laboratory Corporation of America Holdings LH	31.5	$ 256.8	-0.13 %	$ 21.4 B	USA
National Research Corporation NRC	10.1	$ 16.46	-0.48 %	$ 368 M	USA
Natera NTRA	17.9	$ 206.16	5.86 %	$ 20.3 B	USA
Neogen Corporation NEOG	62.7	$ 9.4	4.33 %	$ 2.04 B	USA
Quest Diagnostics Incorporated DGX	14.7	$ 194.2	2.58 %	$ 21.6 B	USA
OpGen OPGN	95	-	-16.95 %	$ 1.54 M	USA
Organovo Holdings ONVO	82.9 K	-	-2.3 %	$ 19.4 M	USA
PerkinElmer PKI	57.9	-	-0.91 %	$ 14.7 B	USA
Exagen XGN	54.5	$ 2.9	5.07 %	$ 62.5 M	USA
Precipio PRPO	23.9	$ 30.9	3.21 %	$ 49.6 M	USA
Burning Rock Biotech Limited BNR	125	$ 17.0	4.68 %	$ 179 M	China
Personalis PSNL	67.3	$ 5.52	9.52 %	$ 327 M	USA